Reuters logo
BRIEF-Pacira Pharmaceuticals prices $300 mln aggregate principal amount of 2.375% convertible senior notes due 2022
2017年3月8日 / 早上6点00分 / 7 个月前

BRIEF-Pacira Pharmaceuticals prices $300 mln aggregate principal amount of 2.375% convertible senior notes due 2022

March 8 (Reuters) - Pacira Pharmaceuticals Inc:

* Pacira Pharmaceuticals announces pricing of $300 million aggregate principal amount of 2.375% convertible senior notes due 2022 Source text for Eikon: Further company coverage:

我们的标准汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below